Picture of Strides Pharma Science logo

STAR — Strides Pharma Science News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Strides Pharma Science Got Tentative USFDA Approval For Dolutegravir/ Lamivudine/ Tenofovir Disproxil Fumurate Tablets

Sept 15 (Reuters) - Strides Pharma Science Ltd
 SRID.NS :
    * STRIDES PHARMA SCIENCE LTD - RECEIVES TENTATIVE USFDA
APPROVAL
FOR DOLUTEGRAVIR/ LAMIVUDINE/ TENOFOVIR DISPROXIL FUMURATE
TABLETS

Source text for Eikon:  ID:nNSE3gyJJ1 
Further company coverage:  SRID.NS 

 ((reuters.briefs@thomsonreuters.com;))

Recent news on Strides Pharma Science

See all news